$SYK

Crotty Dylan Bram sold $145K of SYK (indirect holdings)

Crotty Dylan Bram (Group President) sold 441 indirectly-held shares of STRYKER CORP (SYK) at $328.60 ($0.14M total) on 2026-08-21.

Original reporting
SEC EDGAR · Crotty Dylan Bram
Published Aug 26, 2026, 8:33 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 26, 2026, 9:55 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$SYK
Neutral
high confidence
Mentioned
$SYK
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$SYKNeutralLow
01

Why it matters

The disclosed sale is routine and does not provide a new trading decision.

02

Market read

Routine insider sale with minimal market impact.

03

What to watch

Potential upcoming earnings or product announcements could give context to the sale.

Relevance 4/10Novelty 4/10Timing: post-market 2026-08-21

Background

SEC Form 4 filing discloses insider transactions for public companies.

Company-level read

Ticker impact

$SYKNeutralHigh confidence
Context

Group President Crotty Dylan Bram sold 441 shares of SYK for $144,914.80 via open-market transaction on 2026-08-21.

Expected impact

No significant impact expected.

Evidence & confidence

Sale size is small relative to market cap and insider holds 6,102 shares after the transaction.

Market effects

None

None

None

Counterpoint

Insider sales sometimes precede negative news, but no other catalyst is indicated.

Key entities

  • Stryker Corp

    Medical device manufacturer (ticker SYK).

  • Crotty Dylan Bram

    Group President of Stryker Corp.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$SYKMed

Stryker completes ZuriMED takeover

Stryker has completed its acquisition of ZuriMED, adding the FiberLocker System for rotator cuff repair to its portfolio. The device, cleared by the FDA in 2024, is designed to reinforce the rotator cuff during or after shoulder repair. Stryker aims to expand its offerings in sports medicine and shoulder care, following strong growth in this segment.

$GDMed

General Dynamics gets $136M to upgrade Stryker power system

General Dynamics Land Systems received a $135.9M contract modification from the U.S. Army to upgrade Stryker armored vehicles' power systems, increasing the total contract value to $162.4M. The contract, running until 2030, covers retrofit kits for existing Strykers, though specifics on quantities and timelines were not disclosed. General Dynamics was the sole bidder. This follows another $54.3M contract for Stryker maintenance and sustainment through 2031.

$SYKHighAI 8/10

Stryker Closes ZuriMED Acquisition Adding Rotator Cuff Technology

Stryker completed its acquisition of privately held ZuriMED Technologies AG, adding the FiberLocker System to its Sports Medicine portfolio. The system, designed to strengthen rotator cuff repairs, received FDA clearance in 2024. Stryker aims to expand its shoulder care capabilities with this acquisition, though financial terms were not disclosed.